These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7400371)

  • 1. Studies on the clinical pharmacokinetics of imidazopyrazole.
    Allen LM; Feely M; Denefrio J
    J Clin Pharmacol; 1980; 20(5-6 Pt 1):341-6. PubMed ID: 7400371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers.
    Berg SL; Blaney SM; Adamson PC; O'Brien M; Poplack DG; Arndt C; Blatt J; Balis FM
    J Clin Oncol; 1998 Jan; 16(1):181-6. PubMed ID: 9440741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic analysis of imidazopyrazole (NSC 51143) in serum.
    Boswell GW; Cohen JL
    J Chromatogr; 1982 Sep; 231(2):485-91. PubMed ID: 7130328
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor.
    Berg SL; Savarese DM; Balis FM; Denicoff AM; Hillig M; O'Shaughnessy JA; Poplack DG; Cowan KH
    Cancer Res; 1993 Jun; 53(11):2587-90. PubMed ID: 7684320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GC analysis of imidazopyrazole in plasma using nitrogen-specific detection.
    Boswell GW; Cohen JL
    J Pharm Sci; 1982 Sep; 71(9):1055-7. PubMed ID: 7131275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dichloroallyl lawsone.
    McKelvey EM; Lomedico M; Lu K; Chadwick M; Loo TL
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):586-90. PubMed ID: 436360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical kinetics of 1, 4-dihydroxy-5,8-bis [(2-[(2-hydroxyethyl) amino] ethyl] amino ]-9, 10-anthracenedione.
    Savaraj N; Lu K; Valdivieso M; Burgess M; Umsawasdi T; Benjamin RS; Loo TL
    Clin Pharmacol Ther; 1982 Mar; 31(3):312-6. PubMed ID: 7060314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the anthrapyrazole anticancer drug CI-941 in plasma and urine by solid-phase extraction and high-performance liquid chromatography.
    Graham MA; Newell DR; Calvert AH
    J Chromatogr; 1989 Jun; 491(1):253-61. PubMed ID: 2793977
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacokinetics of topotecan.
    Herben VM; ten Bokkel Huinink WW; Beijnen JH
    Clin Pharmacokinet; 1996 Aug; 31(2):85-102. PubMed ID: 8853931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of pyrazoloacridine in the rhesus monkey.
    Berg SL; Balis FM; McCully CL; Godwin KS; Poplack DG
    Cancer Res; 1991 Oct; 51(20):5467-70. PubMed ID: 1913666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the human pharmacokinetics of isophosphamide (NSC-109724).
    Allen LM; Creaven PJ; Nelson RL
    Cancer Treat Rep; 1976 Apr; 60(4):451-8. PubMed ID: 1277221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue distribution and plasma pharmacokinetics of UCN-01 at steady-state and following bolus administration in rats: influence of human alpha1-acid glycoprotein binding.
    Hedaya MA; Daoud SS
    Anticancer Res; 2001; 21(6A):4005-10. PubMed ID: 11911284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patients.
    Takimoto CH; Dahut W; Marino MT; Nakashima H; Liang MD; Harold N; Lieberman R; Arbuck SG; Band RA; Chen AP; Hamilton JM; Cantilena LR; Allegra CJ; Grem JL
    J Clin Oncol; 1997 Apr; 15(4):1492-501. PubMed ID: 9193345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril kinetics.
    Duchin KL; Singhvi SM; Willard DA; Migdalof BH; McKinstry DN
    Clin Pharmacol Ther; 1982 Apr; 31(4):452-8. PubMed ID: 7037265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics and pharmacodynamics of sulfinalol hydrochloride in dogs after intravenous administration.
    Park GB; Koss RF; DeFelice AF; O'Neil SK; Edelson J
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):4-13. PubMed ID: 6129834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of 9-aminocamptothecin in children with refractory solid tumors: a Pediatric Oncology Group study.
    Langevin AM; Casto DT; Thomas PJ; Weitman SD; Kretschmar C; Grier H; Pratt C; Dubowy R; Bernstein M; Blaney S; Vietti T
    J Clin Oncol; 1998 Jul; 16(7):2494-9. PubMed ID: 9667269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1.
    Foster BJ; Wiegand RA; LoRusso PM; Baker LH
    Clin Cancer Res; 1995 Aug; 1(8):831-7. PubMed ID: 9816052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma kinetics of mitoxantrone in leukemic patients.
    Hulhoven R; Dumont E; Harvengt C
    Med Oncol Tumor Pharmacother; 1984; 1(3):201-4. PubMed ID: 6544900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of homoharringtonine.
    Savaraj N; Lu K; Dimery I; Feun LG; Burgess M; Keating M; Loo TL
    Cancer Treat Rep; 1986 Dec; 70(12):1403-7. PubMed ID: 3791253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.